Overview
Renier Myburgh practices in Zurich, Switzerland. Mr. Myburgh is rated as a Distinguished expert by MediFind in the treatment of Myeloperoxidase Deficiency. His top areas of expertise are Myeloperoxidase Deficiency, Acute Myeloid Leukemia (AML), Leukemia, and Systemic Mastocytosis.
His clinical research consists of co-authoring 27 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Myeloperoxidase Deficiency.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Myeloperoxidase DeficiencyMr. Myburgh isDistinguished. Learn about Myeloperoxidase Deficiency.
- Advanced
- Acute Myeloid Leukemia (AML)Mr. Myburgh isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Experienced
- HIV/AIDSMr. Myburgh isExperienced. Learn about HIV/AIDS.
- Langerhans Cell HistiocytosisMr. Myburgh isExperienced. Learn about Langerhans Cell Histiocytosis.
- LeukemiaMr. Myburgh isExperienced. Learn about Leukemia.
- Mast Cell Activation Syndrome (MCAS)Mr. Myburgh isExperienced. Learn about Mast Cell Activation Syndrome (MCAS).
- MyelofibrosisMr. Myburgh isExperienced. Learn about Myelofibrosis.
- Systemic MastocytosisMr. Myburgh isExperienced. Learn about Systemic Mastocytosis.